<DOC>
	<DOC>NCT01213173</DOC>
	<brief_summary>The purpose of this study is to evaluate the effects of Succinate Metoprolol(Betaloc ZOK®) (95 - 190 mg) on heart rate in the Stable angina patients.</brief_summary>
	<brief_title>Evaluation of Succinate Metoprolol on Heart Rate in the Stable Angina Patients</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina, Stable</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Provision of informed consent prior to any study specific procedures Chinese patients Heart rate ≥ 65bpm Has been diagnosed as Stable angina for at least 1 month and with stable angina pectoris symptoms within 2 weeks previous to enrolment(Please find the diagnose criteria of Stable angina on Appendix C) With Left ventricular ejection fraction ≥ 50% according to ultrasound cardiogram; Has been on betablockers for at least 4 weeks*, on the dose equivalent to Betaloc ZOK® 23.7547.5mg/day. Acute myocardial infarction within 6 months Unstable angina or Prinzmetal's angina II degree of AV block or greater Significant clinical, laboratory or electrocardiographic abnormalities that would place the subject at undue risk (in the Investigator's opinion) including: Significant renal impairment (serum creatinine &gt; 2.0 mg/dL) Serum Alanine Aminotransferase or Aspartate Aminotransferase &gt; 3 x upper limit of reference range Serum potassium &lt; 3.0 mEq/L Serum sodium ≤ 130 mEq/L Acute or chronic hepatitis or cirrhosis (clinical diagnosis) Uncontrolled hyperthyroidism (clinical diagnosis) Systolic blood pressure ≥ 180 mmHg, or &lt; 100mmHg at enrolment Patients with unstable, not compensated heart failure (pulmonary oedema, hypoperfusion or hypotension)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>angina pectoris</keyword>
	<keyword>chest pain</keyword>
	<keyword>heart rate</keyword>
</DOC>